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46 The Journal of Thoracic and Cardiobjective: This study aims to report our experience using intraoperative device
losure of secundum atrial septal defects and to evaluate the feasibility and clinical
utcome of this technique.
ethods: One hundred patients with secundum atrial septal defects (mean age, 29
6 years; age range, 5–71 years; mean weight, 54 18 kg; weight range, 16–94 kg)
nderwent intraoperative device closure through a right minithoracotomy without
ardiopulmonary bypass and fluoroscopy. A 2.5- to 3-cm parasternal or submam-
ary incision was made in the right third or fourth intercostal space. Exposed with
miniretractor, a specially designed plastic sheath loaded with the device was
nserted through the purse-string sutures placed on the right atrium. Under trans-
sophageal echocardiographic guidance, it was advanced through the atrial septal
efect into the left atrium, and the device was deployed in place.
esults: The procedure was successful in all patients, including 5 patients with
ouble atrial septal defects. The maximum diameter of the atrial septal defect ranged
rom 5 to 37 mm (mean, 21  7 mm). There were 61 patients with an atrial septal
efect diameter of more than 20 mm, 16 of them with a diameter of more than 30
m. The mean size of implanted devices was 25  7 mm (range, 8–36 mm).
esidual shunts were found in 9 (9%) patients immediately after the operation. The
omplete occlusion rate was 95% at discharge, 99% at the 3-month follow-up, and
00% at the 1-year follow-up. There were no other late complications during the
ollow-up period.
onclusions: Intraoperative device closure is a safe, cost-effective, cosmetic, and
ess-invasive operation of most secundum atrial septal defects. Follow-up results are
ncouraging. It can be considered an acceptable alternative to transcatheter closure
r surgical repair.
urgical closure has been considered the gold standard treatment for patients
with secundum atrial septal defects (ASDs) for many years. However, it is
associated with morbidity, discomfort, and an unsightly scar.1 Although techno-
ogical advances, such as minimally invasive surgery, have been made with excellent
esults,2 operative trauma still occurs and cardiopulmonary bypass (CPB) is still needed.
PB is widely recognized as having a number of adverse effects.3
In 1976, King and colleagues4 performed the first transcatheter occlusion of a
ecundum ASD in a patient. Since then, transcatheter closure of ASD has been
ncreasingly improved and is becoming an effective alternative to surgical inter-
ention.5 But the costs of this technique are much higher than those of surgical
ntervention in third-world countries,6 and it still has been associated with occa-
ional serious complications. Surgical back-up is often needed.7,8
We describe an intraoperative device closure (IODC) of secundum ASD, in
hich the defect was closed through a right minithoracotomy under transesophageal
vascular Surgery ● October 2007
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Dchocardiographic (TEE) guidance without CPB and fluo-
oscopy. It has less-invasive and better cosmetic results than
as surgical repair. Like transcatheter closure, it is safe and
uch cheaper in third-world countries. This study reports
ur experience and current outcome with the application of
his new technique.
aterials and Methods
atients and Clinical Details
etween July 2001 and October 2006, 100 patients with a secun-
um ASD underwent ASD closure with septal occlusion devices
hrough a right anterior minithoracotomy. All patients received
iagnoses based on initial transthoracic echocardiography (TTE)
nd were considered for IODC. Among them, 39 were male, and
1 were female. The mean age was 29  16 years (range, 5-71
ears), and the body weight was 54  18 kg (range, 16-94 kg).
wenty children less than 12 years of age were asymptomatic.
hree patients were treated with IODC after an attempt at trans-
atheter closure failed.
Routine examinations before surgical intervention included
tandard electrocardiography (ECG), chest radiography, TTE, and
lood tests. All patients were informed about IODC and consented
o have the procedure. The ethics committee of our hospital ap-
roved this new technique.
mplantation of the Device
EE. The patient was placed in a supine position after achieve-
ent of general anesthesia with a single-lumen tracheal intubation.
EE was performed to assess the defect and its surrounding rims
t the time before the operation as part of the closure protocol.
The maximum longitudinal and horizontal diameters of
he defect were measured in the standard TEE views to determine
hether the ASD was round or elliptical. In patients with double
SDs, the size of the 2 defects, as well as the edge-to-edge
istance between the communications, was measured. The supero-
osterior rim and the inferoposterior rim were measured as the
uperior vena caval (SVC) rim and inferior vena caval (IVC) rim,
espectively. The rims from the margin of the defect to the aortic
nnulus (aortic rim), coronary sinus, atrioventricular valves, and
ight upper pulmonary vein was also measured. The total atrial
eptal lengths were obtained by using long-axis views of the atrial
eptum.
Patient inclusion criteria for IODC were as follows: (1) pres-
Abbreviations and Acronyms
ASD  atrial septal defect
CPB  cardiopulmonary bypass
ECG  electrocardiography
IODC intraoperative device closure
IVC  inferior vena cava
SVC  superior vena cava
TEE  transesophageal echocardiography
TTE  transthoracic echocardiographynce of a secundum ASD, including part of double ASD; (2) the w
The Journal of Thoracicims from the above structures, except the aortic rim, must be
mm or larger, especially the IVC and SVC rims; (3) total length
f the atrial septum not smaller than the diameter of the left disk
f the chosen device; and (4) no other coexisting cardiac
nomalies.
Device selection. The double-disk device is the same as that
sed in the transcatheter approach. A sizing balloon is not used in
ODC. If the ASD is round or similar to round in shape, the device
ize is selected by adding 4 to 6 mm to the maximum ASD
iameter. If the ASD is elliptical, the device is chosen with a size
qual to or up to 4 mm larger than the maximum longitudinal
iameter. As for double ASDs, the size is selected by adding 4 or
mm to the sum of the diameter of the larger defect and the
dge-to-edge distance between the communications.
Operative technique. A 2.5- to 3-cm incision was made in the
ight anterior third or fourth intercostal space of the right sternal
order. The exact location of the incision was chosen according to
he chest film where the most prominent part of the right atrium
as projected. For the female patients, a right submammary inci-
ion (Figure 1) was used within the “bikini lines.” Exposure was
ptimized with a miniretractor. The pericardium was incised like
n H and cradled with four 2-0 Ethibond (Ethicon, Inc, Somerville,
J) stay sutures. Two parallel purse-string sutures of 4-0 or 5-0
rolene (Ethicon, Inc) were placed on the right atrium, with a
iameter of about 10 mm. Heparin was then administered at
.0 mg/kg to achieve an activated clotting time of greater than 200
econds at the time of device deployment.
The delivery system included a short plastic sheath with a side
rm and a delivery cable (Figure 2). Two sizes of delivery sheaths
10F or 14F) were used in the operation. The sheath was allowed
o draw blood from the side arm to ensure there was no air
ntrapment. The selected device was immersed in heparinized
aline (0.5 mg/mL) and screwed on to the delivery cable. With the
ip outside, the device was loaded into the sheath. A right atrial
uncture was made within the purse-string sutures, and the sheath
igure 1. A 2.5-cm right anterior submammary incision within the
bikini lines.”as inserted. Under TEE guidance, it was advanced through the
and Cardiovascular Surgery ● Volume 134, Number 4 947
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DSD into the left atrium. After drawing blood from the side arm
or further deairing, the left atrial disk was extruded first by
dvancing the delivery cable. Adjusting the left disk to be parallel
ith the atrial septum, the sheath and the cable were withdrawn in
nison until resistance was met from the atrial septum. The waist
nd the right disk were deployed subsequently (Figure 3, A).
Once the device was fully deployed across the ASD (Figure 3,
), its stability was checked by using a push-pull maneuver re-
igure 2. The delivery system includes a plastic sheath with a
ide arm and a delivery cable.
igure 3. A, Under TEE guidance, the left atrial disk was extruded
rst, and the right atrial disk was deployed subsequently while
raction was maintained on the delivery cable. B, The device was
ully deployed across the ASD. TEE, Transesophageal echocardi-8graphy; ASD, atrial septal defect.
48 The Journal of Thoracic and Cardiovascular Surgery ● Octoeatedly, and its position was assessed by means of TEE. If the
evice was unstable or any obvious residual shunt, as well as any
ncroachment of the device on the adjacent structures, was dis-
overed by using TEE, redeployment of the device would have to
e undertaken. After release, the device was detected again by
sing TEE. Then the sheath was withdrawn, with the purse-string
uture snugly tied. The stab-wound incision was closed with no
rainage tube placement.
atient Follow-up
fter the operation, heparin was given to the patients for 24 hours
250 U/kg), and aspirin (3-4 mg · kg1 · d1) was continued for
months. All patients were instructed to use antibiotics and
ndomethacin for prophylaxis of bacterial endocarditis and post-
ardiotomy syndrome, respectively.
Follow-up examinations, including ECG and TTE, were sched-
led at discharge and 3, 6, and 12 months and yearly thereafter.
tatistical Analysis
ata are expressed as means  standard deviations and ranges.
esults
ntraoperative Results
linical demographic data of all patients are listed in Table 1.
he maximum diameter of the ASD ranged from 5 to 37
m (mean, 21 7 mm). There were 45 patients with ASDs
f 20 to 29 mm in diameter and 16 patients with ASDs of
arger than 30 mm. Five patients had double defects, with
he size of the larger defect ranging from 10 to 25 mm and
he distance between the communications ranging from 3 to
mm.
Successful implantation of the device was achieved in all
atients, including the 5 patients with double ASDs oc-
luded with a single device through the larger defect. The
ean size of implanted devices was 25  7 mm (range,
able 1. Patient statistical analysis for IODC
ariable Value
atient no. 100
ge (y) 29 16 (range, 5–71)
ex (F/M) 61/39
eight (kg) 54 18 (range, 16–94)
aximum diameter of
ASD (mm)
21  7 (range, 5–37)
5-19 mm (n) 39
20-29 mm (n) 45
30-37 mm (n) 16
VC rim (mm) 13 5 (range, approximately 5–26)
VC rim (mm) 12 4 (range, approximately 5–28)
mplanted device (mm) 25 7 (range, 8–36)
ouble defects (n) 5
ODC, Intraoperative device closure; ASD, atrial septal defect; SVC, supe-
ior vena cava; IVC, inferior vena cava.-36 mm).
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DCorrect placement of the device at the first attempt was
chieved in 82 (82%) patients. Redeployment of the device
as necessary in 18 patients. In 10 of them, the device was
eplaced with a larger one because of the unstable position
nd residual shunt. In 8 patients the device was overesti-
ated and needed to be changed with a smaller one. Two of
hem presented with myocardial ischemia on ECG imme-
iately after the first deployment because of obstruction of
he coronary sinus, 3 were found to have encroachment of
he device on the movement of the mitral valve, and the final
were those in whom the devices appeared bulky because
f the inaccurate measurements of TEE. No conversion
rom the IODC to conventional surgical intervention was
equired.
ostoperative Results
eventy-five percent of the operations were accomplished
ithin an hour. The average intracardiac manipulation time
as 15  13 minutes (range, 2-45 minutes). The patients
ere extubated on the operating table or within 2 hours in
he recovery room.
Hydrothorax was noted in 3 patients, and removal of the
leural effusion was undertaken subsequently. Temporary
inus bradycardia was found in 12 patients, who were easily
reated medically. Ninety-seven (97%) patients did not re-
uire any blood products. Blood loss occurred in 3 early
ases because of lack of experience. Postoperative length of
tay was 3 to 4 days, except for 3 patients with hydrothorax.
The total follow-up period ranged from 2 to 60 months
mean, 25  17 months). The follow-up results were avail-
ble by means of TTE in 100 patients at 3 months, in 94
atients at 6 months, in 81 patients at 1 year, in 59 patients
t 2 years, and in 35 patients at more than 4 years. Residual
hunts were found in 9 (9%) patients immediately after the
peration. Four were trivial, 3 were small, and 2 were
oderate.9 The complete occlusion rate was 95% at dis-
harge, 99% at 3 and 6 months, and 100% at or after the
-year follow-up. There was no incidence of device malpo-
ition, embolization, or other late complications. All pa-
ients or their guardians were pleased with their cosmetic
esults.
iscussion
urgical closure has been considered a standard technique
or patients with ASDs since the 1950s. This method was
erformed with a very low morbidity and no mortality and
ielded optimal long-term results.1,2,10 However, operative
rauma and an unsightly scar can cause psychological dis-
ress in patients. Although current minimally invasive ap-
roaches have been applied with better cosmetic results,2
he restrictive exposure of the heart turns a simple and safe
peration into a technically difficult procedure that entails
otential risks, such as injury to the great vessels and air d
The Journal of Thoracicmbolism. Moreover, these techniques are just intended to
ake the skin incision less prominent; CPB and its delete-
ious effects still exist.3
Since the first clinical trials with the Amplatzer septal
ccluder (AGA Medical Corp) in the 1990s,11 many favor-
ble results compared with those of conventional surgical
losure have been reported. These include superior cosmetic
esults, less trauma, avoidance of CPB, and a shorter hos-
ital stay.5,12 However, this technique still has been associ-
ted with occasional serious complications, such as device
mbolization, vessel injury, and even perforation of the
eart.7,8 Additionally, this technique needs more advanced
quipment, and the costs are much higher than those of
urgical intervention. This makes it difficult to popularize
he use of this technique in developing countries,6 where
ealth care resources are limited.
The advantages of IODC, when compared with those of
urgical intervention, can be summarized as follows: CPB is
ot used, there is no need for a drainage tube and blood
ransfusion, and operative trauma is minimized. These
ight result in less pain, quick recovery, shorter hospital
tay, and better cosmetic results.13,14 Because of the right
trium not being opened and the special design of the
elivery sheath, there is almost no probability of air embo-
ism occurring during the procedure.
There are several theoretical advantages of IODC com-
ared with those of the classic transcatheter procedure,
hich can be speculated as follows.
The first is that it is easier to guide the delivery sheath
cross the defect and anchor the device properly. In the
rocess of IODC, the sheath approaches the ASD directly,
nd therefore the position of the left disk is easier to adjust
ith the short sheath than that of the transcatheter approach
ith a long delivery sheath, in which there is a right angle
etween the septum and the IVC. In patients with ASDs of
deficient rim, the surgeon can push the sheath by hand
gainst the short rim and deploy the device in the proper
osition, which is unattainable in the transcatheter ap-
roach. In our series there were 61 patients with a defect of
reater than 20 mm in diameter and 16 of them with a defect
f greater than 30 mm. IODC was a success in all of them.
The second advantage is that more stability and feasibil-
ty of the device closure is available with IODC. Because
he delivery cable is perpendicular to the atrial septum, the
urgeon can test the stability of the device with more
trength on it by using a push-pull maneuver after deploy-
ent. In addition, it is almost impossible to perforate the
eart because no guide wires are used in IODC. Even if
evice embolization or perforation of the heart occurred, the
atient could be saved immediately by extending the orig-
nal incision for conversion to CPB surgery.
Third, in IODC there is no need for the complex long
elivery system, including use of a balloon catheter and
and Cardiovascular Surgery ● Volume 134, Number 4 949
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Duide wires. There is no need for fluoroscopy and angiog-
aphy. As with the transcatheter approach, IODC has the
dvantages of avoidance of CPB and intensive care unit
tay, a short hospital stay, and no use of blood products.
ecause of its simplicity, only a short learning curve is
equired for surgeons, and less equipment is needed in this
rocedure compared with transcatheter closure. This leads
o less resource use and reduced costs.
Lastly, transcatheter closure is more complicated in
mall children in whom the femoral sheath is prohibitively
arger, whereas a larger device is needed. This would not
appen in IODC unless the left atrium is too small or the
urrounding rims of the ASD are deficient or absent.
TEE plays an important role in IODC.14-16 IODC re-
uires precise measurements of the size of an ASD, irre-
pective of its shape. This is important in choosing the
evice size. In patients with round or elliptical ASDs, we
hose the device, respectively, with a diameter of 4 to 6
m or 0 to 4 mm larger than the maximum diameter of
he ASD. If an apparent residual shunt or a deformation
f the disks occurred after deployment, the device should
e retrieved and redeployed by exchanging it for a lager
r smaller one.17
The other key feature in IODC is the surrounding rims of
he ASD. A minimum of a 5-mm rim of atrial septum
round the defect has been suggested as a prerequisite for
evice closure.11,15,16 This minimal rim length is crucial for
afe and stable positioning of atrial disks.17 Recent studies
ndicate18,19 deficiency in the anterior superior rim did not
nfluence the success rate of ASD closure with the Am-
latzer device. The same result was obtained in our cohort.
ccording to our experience, the most important rim is the
VC and SVC rim in IODC. The aortic rim is the least
mportant and is usually absent in larger defects.
We had 5 patients with double defects who underwent
uccessful closure with 1 device. In the literatures15,20 the
evice must stent the larger defect, and the neighboring hole
hould be closed with lateral pressure or by covering with
he left disk. The distance between the defects is an impor-
ant factor. We chose the size of the device by adding 4 or
mm to the sum of the diameter of the larger defect and the
dge-to-edge distance between the defects.
An additional consideration in IODC is the length of the
nteratrial septum, which should be sufficient to accommo-
ate the device. Because the left disk is 12 to 14 mm larger
han the waist, the size of the device added 12 to 14 should be
ess than the interatrial septal length.17 If there is not enough
pace for the configuration of the device within the left or right
trium, this can cause deformation of the device after deploy-
ent and sometimes encroachment on the mitral valve.
Residual shunt is a common complication in device
losure of ASDs. Midterm follow-up of transcatheter clo-
ure of ASDs reports residual shunts in between 0% and 4%
50 The Journal of Thoracic and Cardiovascular Surgery ● Octof patients.5,19 Trivial or small residual shunts immediately
fter the release of the device need not be of too much
oncern.16 They usually disappear during the follow-up
eriod.
Our study has several limitations. When discussing cost
avings, no data are available comparing the costs between
ODC and transcatheter closure. Our sample did not include
mall children, and we know that device closure in small
hildren (15 kg) is more challenging and complicated.
lthough we observed a complete occlusion rate of 100%
nd no serious complications occurred during the follow-up
eriod, we still do not know whether the devices are safe in
he very long term.
onclusions
ODC is a safe, cost-effective, cosmetic, and less-invasive
peration of most secundum ASDs. Follow-up results are
ncouraging. It can be considered an acceptable alternative
o transcatheter closure or surgical repair.
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